1. Inhibition of aquaporin-3 in macrophages by a monoclonal antibody as potential therapy for liver injury
    Mariko Hara-Chikuma et al, 2020, Nature Communications CrossRef
  2. Recent progress in adverse events of carboxylic acid non-steroidal anti-inflammatory drugs (CBA-NSAIDs) and their association with the metabolism: the consequences on mitochondrial dysfunction and oxidative stress, and prevention with natural plant extracts
    Yanan Liu et al, 2024, Expert Opinion on Drug Metabolism & Toxicology CrossRef
  3. The comparative effects of diethyldithiocarbamate–copper complex with established proteasome inhibitors on expression levels of CYP1A2/3A4 and their master regulators, aryl hydrocarbon and pregnane X receptor in primary cultures of human hepatocytes
    Radim Vrzal et al, 2016, Fundamental & Clinical Pharmacology CrossRef
  4. A comprehensive review of cytochrome P450 2E1 for xenobiotic metabolism
    Jingxuan Chen et al, 2019, Drug Metabolism Reviews CrossRef
  5. Molecular Biomarkers in Drug-Induced Liver Injury: Challenges and Future Perspectives
    Siyu Fu et al, 2020, Frontiers in Pharmacology CrossRef
  6. Carfilzomib Mitigates Lipopolysaccharide/D-Galactosamine/Dimethylsulfoxide-Induced Acute Liver Failure in Mice
    Dhafer Alhareth et al, 2023, Biomedicines CrossRef
  7. Hepatoprotective Activity of Leptadenia hastata (Asclepiadaceae) on Acetaminophen-Induced Toxicity in Mice: In Vivo Study and Characterization of Bioactive Compounds through Molecular Docking Approaches
    Borris R. T. Galani et al, 2020, BioMed Research International CrossRef
  8. A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes
    Sun-Hye Shin et al, 2020, International Journal of Molecular Sciences CrossRef
  9. Reducing Hepatotoxicity Mechanism of Radix Wikstroemia Indica by Processing with “Sweat Soaking Method” Using UPLC-MS/MS and a Cocktail Probe Substrate
    Hongmei Su et al, 2023, Letters in Drug Design & Discovery CrossRef
  10. A review of challenges and prospects of 3D cell-based culture models used for studying drug induced liver injury during early phases of drug development
    John K Chipangura et al, 2023, Human & Experimental Toxicology CrossRef
  11. Proteasome inhibition protects against diet-induced gallstone formation through modulation of cholesterol and bile acid homeostasis
    Eun‑Ji Lee et al, 2017, International Journal of Molecular Medicine CrossRef
  12. Role of gambogenic acid in regulating PI3K/Akt/NF-kβ signaling pathways in rat model of acute hepatotoxicity
    Zhongyang Ding et al, 2021, Bioscience, Biotechnology, and Biochemistry CrossRef
  13. The Role of Carbamoyl Phosphate Synthetase 1 as a Prognostic Biomarker in Patients With Acetaminophen-induced Acute Liver Failure
    Raymond Kwan et al, 2023, Clinical Gastroenterology and Hepatology CrossRef
  14. Chemical-induced liver cancer: an adverse outcome pathway perspective
    Julen Sanz-Serrano et al, 2024, Expert Opinion on Drug Safety CrossRef
  15. Sialic Acid Engineered Prodrug Nanoparticles for Codelivery of Bortezomib and Selenium in Tumor Bearing Mice
    Sarita Rani et al, 2023, Bioconjugate Chemistry CrossRef
  16. Serum indicators in functional high-risk multiple myeloma patients undertaking proteasome inhibitors therapy: a retrospective study
    Linquan Zhan et al, 2024, Hematology CrossRef